One of the biggest challenges facing clinical trial sponsors and investigational sites centers on the efficient identification, recruitment and ongoing […]
A study from the Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate […]
Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an Investigator Initiated Trial (IIT) targeting MRI-Ultrasound fusion […]
China’s Hinova Pharmaceuticals closed nearly $146 million in a series C round investment to support multicenter clinical trials and the […]
Piedmont Healthcare is participating in two clinical research trials to study treatments for prostate cancer. One study examines the effects […]
A privately-held Seattle-based biotechnology company secured $1.44 million on the second of a competitive Small Business Innovation Research (SBIR) Phase […]
University of South Australia researchers demonstrate that a new formulation of a prostate cancer treatment known as abiraterone acetate (Zytiga) […]
TrialSite News recently had the honor of interviewing Graham Kelly, a brilliant scientist, researcher, and Executive Chairman and CEO of […]
An elite scientific team developing new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at Abramson Cancer Center […]
Researchers from the Sidney Kimmel Cancer Center—Jefferson Health, Rutgers Cancer Institute and others are suggesting that among high-risk prostate cancer […]
